Clinical manifestations and etiology in stroke patients with cancer: usefulness of coagulation and fibrinolytic markers
スポンサーリンク
概要
- 論文の詳細を見る
OBJECTIVE : We analyzed the incidence and types of strokes in cancer patients, and evaluated the clini-cal utility of coagulation and fibrinolytic markers in cancer patients as compared to non-cancer patients.<BR>METHODS : A retrospective review of all ischemic strokes between January 2000 and December 2005 was conducted. Seventy-four patients (males, 53; females, 21) were identified. Age, gender, cancer diagnosis and histology, and vascular risk factors were recorded. The following coagulation and fibrinolytic parameters were examined : thrombin-antithrombin III complex (TAT), FDP D-dimer, α<SUB>2</SUB>-plasmin inhibitor/plasmin complex (PIC), antithrombin III (AT-III), fibrinogen (FIB), and platelet cell count.<BR>RESULTS: The strokes were embolic in 45 patients (60.8%) and thrombotic in 29(39.2%). The most com-mon primary tumor was gastric cancer (23%). The most common histopathology was adenocarcinoma (60.8%). Both mean D-dimer levels were higher in the malignant patients as compared to the controls (D-dimer: 15.4 ± 21.6μg/ml vs. 3.9 ± 6.8μg/ml, p<0.05). An increased serum CA19-9 level was correlated with the serum D-dimer level (CA19-9 vs. D-dimer : R = 0.37, p<0.05) .<BR>CONCLUSION : Activation of the coagulation system in cancer patients was more closely related to the cause of stroke than in patients without cancer ; that is to say, increased serum D-dimer levels might have the possibility to become predictors of stroke onset.
- 一般社団法人 日本脳卒中学会の論文
一般社団法人 日本脳卒中学会 | 論文
- Two cases with aphasia in the left putaminal damage and one case with visuospatial neglect in the right putaminal damage
- Alterations of plasma von Willebrand factor activity and the influence of anti-platelet drugs in acute cerebral infarction
- Carotid endarterectomy plaques correlation of clinical events and morphology.
- Stenting for stenosis of major cerebrovascular arteries.
- Cerebral infarction following antihypertensive therapy.